Evidence map›Paper›PMID 41758815›Full record

ArticlePloS one2026

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study.

Audrey Laurin, Floriane Rousseaux, Valentyn Fournier, Jean Roy, Mathieu Landry, Richard LeBlanc, Nadia Godin, Caroline Arbour, Philippe Richebé, Karim Jerbi and 2 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06817759 (Study Protocol for the Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Myeloma and Lymphoma During Stem Cell Transplant), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06817759 nanot yet recruitingnot on this map

Study Protocol for the Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Myeloma and Lymphoma During Stem Cell Transplant: a Pilot Randomized Clinical Trial

TypeinterventionalSponsorCiusss de L'Est de l'Île de MontréalRan2025 to 2025Enrolled60ConditionsBlood Cancer, Multiple Myeloma (MM), LymphomaArmsVirtual Reality Hypnosis, VRH : Beach, VRH : Forest, VRH : MagicHand, VRH : SecurityProtection
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Audrey LaurinDepartment of Psychology, Faculty of Arts and Sciences, University of Montreal, Montreal, Canada.
Floriane RousseauxMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.ORCID https://orcid.org/0000-0003-1998-5471
Valentyn FournierMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.ORCID https://orcid.org/0000-0002-1289-8968
Jean RoyMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.
Mathieu LandryDepartment of Psychology, Faculty of Arts and Sciences, University of Montreal, Montreal, Canada.
Richard LeBlancMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.
Nadia GodinMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.
Caroline ArbourFaculty of Nursing, University of Montreal, Montreal, Canada.
Philippe RichebéDepartment of Anesthesiology and Intensive Care, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France.
Karim JerbiDepartment of Psychology, Faculty of Arts and Sciences, University of Montreal, Montreal, Canada.
Pierre RainvilleFaculty of Dentistry, University of Montreal, Montreal, Canada.
David OgezMaisonneuve-Rosemont Hospital Research Center, Montreal, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStem cell transplantation is a highly stressful treatment for hematological cancer patients, negatively impacting their quality of life. Hypnosis has proven effective in managing symptoms like pain, fatigue, and anxiety, and improving quality of life. Virtual reality (VR) is used in cancer treatments to distract from pain, and combining VR with hypnosis (VRH) could enhance the hypnotic experience. However, methodological limitations in current studies prevent clear evaluation of its effectiveness, particularly for individualized care and psychosocial interventions.

aims1) To evaluate the preliminary effects of VRH in reducing anxiety, pain, and fatigue during stem cell transplant, improving quality of life post-intervention. 2) To assess intervention feasibility, including patients' experiences, satisfaction levels, and recommendations for improving the VRH tool.

methodsThis study will involve 60 hematology patients divided into two groups: VRH and waiting list. Anxiodepressive symptoms, pain, quality of life, fatigue, absorption, dissociation, and amusement will be assessed before, immediately after the intervention, and at one- and three-month follow-ups using validated psychological scales and numeric rating scales (0-10). Semi-structured interviews will capture patient expectations, satisfaction, and feedback. Data will be analyzed using MANOVA (or non-parametric alternatives) and thematic analysis. DISCUSSION: The study's primary goal is to assess VRH's effectiveness compared to standard care in a feasibility randomized controlled trial (RCT). It will also provide data for improving the VRH tool (version 2.0) and assess its usability. In the long term, findings will help integrate VRH into oncology clinics, offering an innovative intervention to support patients throughout treatment. CLINICALTRIAL REGISTRATION: ClinicalTrials.gov NCT06817759.

Indexed as

Hematologic NeoplasmsHypnosisStem Cell TransplantationVirtual RealityAdultAnxietyFatigueFeasibility StudiesFemaleHumansMaleMiddle AgedPainQuality of LifeRandomized Controlled Trials as Topic

Identifiers

PMID41758815
PMCPMC12948061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.